Author: Jasmine Riviere Marcelin, MD

Introducing a new Nebraska DHHS funded UNMC ID ECHO Educational Series

Introducing a newly launched educational initiative, the UNMC ID Health equity and Quality Improvement ECHO Project. The goal of the program is to achieve health equity, address COVID-19 disparities, and improve the health of all Nebraskans using a quality improvement approach. The course is being offered at no cost to the learners through the University […]

Oct 26, 2021

We appreciate our ID Pharmacists

We LOVE our UNMC ID Pharmacists! Today marks the end of National Pharmacy Week and we want to share our appreciation and thanks for the hard work and invaluable contributions of our pharmacists at UNMC ID. Our pharmacists are exceptional clinicians giving us the clinical advice we need on antimicrobials and drug interactions. They are […]

Oct 22, 2021

Publication Alert: Structural Vulnerability among Patients with HIV and SARS-CoV-2 Co-Infection

Publication Alert: Structural Vulnerability among Patients with HIV and SARS-CoV-2 Co-Infection. This content was provided by Natasha Hongsermeier-Graves, MD/MPH student at UNMC College of Medicine/Harvard School of Public Health. She led a recently published study, collaborating with another UNMC medical student Rohan Khazanchi, and UNMC ID faculty Drs. Jasmine Marcelin and Nada Fadul.

Oct 19, 2021

Looking forward to meeting you at the #IDWeek2021 Virtual Career Fair!

Looking for your first position out of fellowship, or your next fulfilling position in your journey? The UNMC ID Division is a robust group comprised of 27 ID physicians, advanced practice providers, pharmacists, and clinical and research support staff. Looking forward to meeting you at the #IDWeek2021 Virtual Career Fair on 10/14/21!

Oct 11, 2021

Welcoming our new Infectious Diseases Pharmacy Resident: Jeremy Tigh PharmD

We are excited to welcome Jeremy Tigh PharmD as a new PGY-2 in our ID Pharmacy Residency Program! He’s the third ID Pharmacy resident we have had and a fantastic addition to our team! Read on to learn a little more about him…

Oct 5, 2021

High-level Review: Updated STI Guidelines Part 2

In July 2021 the Center for Disease Control and Prevention (CDC) released their sexually transmitted infections (STI) treatment guideline, an update from 2015.1 Below, senior ID fellow Dr. Jonathan Ryder highlights significant (but by no means comprehensive) changes in this new guideline that can be incorporated into clinical practice and some of the evidence supporting these changes. Part 2 – Bacterial Vaginosis, Trichomonas, Pelvic Inflammatory Disease

Sep 7, 2021

High-level Review: Updated STI Guidelines Part 1

In July 2021 the Center for Disease Control and Prevention (CDC) released their sexually transmitted infections (STI) treatment guideline, an update from 2015.1 Below, senior ID fellow Dr. Jonathan Ryder highlights significant (but by no means comprehensive) changes in this new guideline that can be incorporated into clinical practice and some of the evidence supporting these changes. Part 1 – Chlamydia, Gonorrhea, Mycoplasma genitalium

Sep 1, 2021

Diversity in Probiotics and Diversity in Clinical Trials: Opportunities for Improvement

This is a Journal Club review by Dr. Jasmine Marcelin of “A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonization” (Rauseo, A. et al. Infection Control & Hospital Epidemiology, (2021).

Aug 17, 2021

Welcoming our New Infectious Diseases Fellows: Dr. Timothy McElroy

We are excited to welcome Dr. Timothy McElroy as a new fellow in our Infectious Diseases program! Read on to learn a little more about him…

Aug 10, 2021

Welcoming our New Infectious Diseases Fellows: Dr. Mackenzie Keintz

We are excited to welcome Dr. Mackenzie Keintz as a new fellow in our Infectious Diseases program! Read on to learn a little more about her…

Aug 4, 2021